分子イメージングの世界市場：市場規模・シェア・動向分析 (モダリティ別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

分子イメージング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の分子イメージングの市場規模は、2025年から2030年にかけてCAGR 4.6%で拡大し、2030年には114億米ドルに達すると推定されています。

市場成長の主な要因としては、技術進歩、がんの有病率の増加、研究開発への投資の増加などが挙げられます。例えば、国際がん研究機関によると、2022年には世界で約1,997万6,499人の新規がん患者と974万3,832人のがん関連死が報告されています。

がん、心血管疾患、神経疾患などの慢性疾患の有病率の増加により、効果的な診断ツールが必要とされており、分子イメージング市場の成長に大きく貢献すると期待されています。PET（Positron Emission Tomography）、SPECT（Single Photon Emission Computed Tomography）、NMR（Nuclear Magnetic Resonance）スペクトロメーターなどの分子イメージング装置は、この点で特に効率的です。これらの先端技術は、様々な疾病に関連する代謝プロセス、分子活動、構造変化に関する詳細な洞察を提供します。これらによって医療専門家は、腫瘍、心機能、神経学的異常の範囲や特徴を高い精度と正確さで可視化し、評価することができます。

さらに、分子イメージングによって、たとえ不顕性の段階であっても疾患の早期発見が容易になり、タイムリーな介入と個別化された治療計画が可能になります。このプロアクティブなアプローチは、患者の予後を改善するだけでなく、進行した病期や合併症に関連する医療費を削減します。

M&A、製品上市、規制当局の承認、提携、共同研究、研究開発（R&D）活動など、市場の主要企業が行う戦略的イニシアチブは、分子イメージング市場の成長を促進する上で重要な役割を果たしています。例えば、2024年1月、Bruker Corporationはオハイオ州立大学のNational Gateway超高磁場NMRセンターに最先端の1.2ギガヘルツ（GHz）NMRシステムの設置に成功しました。このGHz級NMRシステムは、核磁気共鳴（NMR）分光法の大きな進歩を象徴するもので、生命科学や材料科学の研究に革命をもたらすことを目指しています。

分子イメージング市場レポートハイライト

• モダリティ別では、単一光子放射型コンピュータ断層撮影（SPECT）セグメントが2024年に43.3%のシェアを獲得して優位を占める。
• 核磁気共鳴（NMR）スペクトロメーターセグメントは、2025年から2030年までのCAGRが8.8%で、最も急成長するセグメントと予測されています。
• 用途別では、世界のがん罹患率の上昇と高度な診断ソリューションへの需要の高まりにより、2024年にがん分野が最大市場シェアを占めました。
• 最終用途別では、臨床現場での先端画像技術の採用が増加していることから、病院分野が2024年に最大の市場シェアを占めました。
• 画像診断センター部門は、大病院と比較して効率的なターンアラウンドタイムで高品質で専門的な画像診断を提供できることから、予測期間中に最も急成長すると予測されています。
• 北米が2024年に41.4％のシェアを占め、市場を独占します。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 分子イメージング市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 分子イメージング市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 分子イメージング市場：モダリティ別の推定・動向分析

• モダリティ別のダッシュボード
• 分子イメージング市場：モダリティ別の変動分析
• 世界の分子イメージング市場：市場規模と動向分析、モダリティ別（2018～2030年）
• 分子超音波イメージング
• 陽電子放出断層撮影（PET）
• 単一光子放出コンピュータ断層撮影（SPECT）
• 核磁気共鳴（NMR）分光計
• その他

第5章 分子イメージング市場：用途別の推定・動向分析

• 用途別のダッシュボード
• 分子イメージング市場：用途別の変動分析
• 世界の分子イメージング市場：市場規模と動向分析、用途別（2018～2030年）
• 心血管系
• 神経学
• 腫瘍学
• 呼吸器
• 胃腸

第6章 分子イメージング市場：最終用途別の推定・動向分析

• 最終用途別のダッシュボード
• 分子イメージング市場：最終用途別の変動分析
• 世界の分子イメージング市場：市場規模と動向分析、最終用途別（2018～2030年）
• 病院
• 診断画像センター
• 研究機関

第7章 分子イメージング市場：地域別推定・動向分析

• 市場ダッシュボード：地域別
• 市場シェア分析：地域別（2024年・2030年）
• 分子イメージング市場：主なポイント、地域別
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最近の動向と影響分析：主要市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 主要企業のヒートマップ分析（2024年）
• 企業プロファイル
  • Bruker
  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • Canon Medical Systems Corporation
  • Mediso Ltd.
  • Cubresa Inc.
  • Shimadzu Corporation
  • United Imaging Healthcare Co., Ltd.
  • Positron

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Molecular Imaging Market, by Region, 2018 - 2030 (USD Million)
• Table 4 Global Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 5 Global Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 6 Global Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 7 North America Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
• Table 8 North America Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 9 North America Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 10 North America Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 11 U.S. Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 12 U.S. Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 13 U.S. Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 14 Canada Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 15 Canada Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 16 Canada Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 17 Mexico Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 18 Mexico Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 19 Mexico Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 20 Europe Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
• Table 21 Europe Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 22 Europe Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 23 Europe Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 24 U.K. Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 25 U.K. Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 26 U.K. Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 27 Germany Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 28 Germany Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 29 Germany Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 30 France Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 31 France Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 32 France Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 33 Italy Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 34 Italy Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 35 Italy Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 36 Spain Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 37 Spain Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 38 Spain Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 39 Denmark Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 40 Denmark Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 41 Denmark Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 42 Sweden Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 43 Sweden Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 44 Sweden Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 45 Norway Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 46 Norway Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 47 Norway Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 52 Japan Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 53 Japan Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 54 Japan Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 55 China Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 56 China Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 57 China Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 58 India Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 59 India Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 60 India Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 61 Australia Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 62 Australia Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 63 Australia Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 64 South Korea Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 65 South Korea Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 66 South Korea Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 67 Thailand Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 68 Thailand Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 69 Thailand Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 70 Latin America Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
• Table 71 Latin America Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 72 Latin America Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 73 Latin America Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 74 Brazil Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 75 Brazil Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 76 Brazil Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 77 Argentina Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 78 Argentina Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 79 Argentina Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 84 South Africa Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 85 South Africa Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 86 South Africa Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 90 UAE Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 91 UAE Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 92 UAE Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
• Table 93 Kuwait Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
• Table 94 Kuwait Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
• Table 95 Kuwait Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Interviews
• Fig. 5 Market Research Approaches
• Fig. 6 Value-Chain-Based Sizing & Forecasting
• Fig. 7 QFD Modeling for Market Share Assessment
• Fig. 8 Market Formulation & Validation
• Fig. 9 Molecular Imaging Market: Market Outlook
• Fig. 10 Molecular Imaging Competitive Insights
• Fig. 11 Parent Market Outlook
• Fig. 12 Related/Ancillary Market Outlook
• Fig. 13 Penetration and Growth Prospect Mapping
• Fig. 14 Industry Value Chain Analysis
• Fig. 15 Molecular Imaging Market Driver Impact
• Fig. 16 Molecular Imaging Market Restraint Impact
• Fig. 17 Molecular Imaging Market Strategic Initiatives Analysis
• Fig. 18 Molecular Imaging Market: Modality Movement Analysis
• Fig. 19 Molecular Imaging Market: Modality Outlook and Key Takeaways
• Fig. 20 Molecular Ultrasound Imaging Market Estimates and Forecast, 2018 - 2030
• Fig. 21 Positron Emission Tomography (PET) Market Estimates and Forecast, 2018 - 2030
• Fig. 22 Single Photon Emission Computed Tomography (SPECT) Market Estimates and Forecast, 2018 - 2030
• Fig. 23 Nuclear Magnetic Resonance (NMR) Spectrometer Market Estimates and Forecast, 2018 - 2030
• Fig. 24 Others Market Estimates and Forecast, 2018 - 2030
• Fig. 25 Molecular Imaging Market: Application Movement Analysis
• Fig. 26 Molecular Imaging Market: Application Outlook and Key Takeaways
• Fig. 27 Cardiovascular Market, 2018 - 2030 (USD Million)
• Fig. 28 Neurology Market, 2018 - 2030 (USD Million)
• Fig. 29 Oncology Market, 2018 - 2030 (USD Million)
• Fig. 30 Respiratory Market, 2018 - 2030 (USD Million)
• Fig. 31 Gastrointestinal Market, 2018 - 2030 (USD Million)
• Fig. 32 Molecular Imaging Market: End Use Movement Analysis
• Fig. 33 Molecular Imaging Market: End Use Outlook and Key Takeaways
• Fig. 34 Hospitals Market, 2018 - 2030 (USD Million)
• Fig. 35 Diagnostic Imaging Centers Market, 2018 - 2030 (USD Million)
• Fig. 36 Research Institutes Market, 2018 - 2030 (USD Million)
• Fig. 37 Global Molecular Imaging Market: Regional Movement Analysis
• Fig. 31 Global Molecular Imaging Market: Regional Outlook and Key Takeaways
• Fig. 38 North America Market Estimates and Forecasts, 2018 - 2030
• Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030
• Fig. 40 Canada Market Estimates and Forecasts, 2018 - 2030
• Fig. 41 Mexico Market Estimates and Forecasts, 2018 - 2030
• Fig. 42 Europe Market Estimates and Forecasts, 2018 - 2030
• Fig. 43 U.K. Market Estimates and Forecasts, 2018 - 2030
• Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
• Fig. 45 France Market Estimates and Forecasts, 2018 - 2030
• Fig. 46 Italy Market Estimates and Forecasts, 2018 - 2030
• Fig. 47 Spain Market Estimates and Forecasts, 2018 - 2030
• Fig. 48 Denmark Market Estimates and Forecasts, 2018 - 2030
• Fig. 49 Sweden Market Estimates and Forecasts, 2018 - 2030
• Fig. 50 Norway Market Estimates and Forecasts, 2018 - 2030
• Fig. 51 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
• Fig. 52 Japan Market Estimates and Forecasts, 2018 - 2030
• Fig. 53 China Market Estimates and Forecasts, 2018 - 2030
• Fig. 54 India Market Estimates and Forecasts, 2018 - 2030
• Fig. 55 Australia Market Estimates and Forecasts, 2018 - 2030
• Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
• Fig. 57 Thailand Market Estimates and Forecasts, 2018 - 2030
• Fig. 58 Latin America Market Estimates and Forecasts, 2018 - 2030
• Fig. 59 Brazil Market Estimates and Forecasts, 2018 - 2030
• Fig. 60 Argentina Market Estimates and Forecasts, 2018 - 2030
• Fig. 61 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 62 South Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 63 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
• Fig. 64 UAE Market Estimates and Forecasts, 2018 - 2030
• Fig. 65 Kuwait Market Estimates and Forecasts, 2018 - 2030

Molecular Imaging Market Growth & Trends:

The global molecular imaging market size is estimated to reach USD 11.4 billion by 2030, expanding at a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights:

• Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.3% in 2024
• The Nuclear Magnetic Resonance (NMR) spectrometer segment is anticipated to be the fastest-growing segment, with a CAGR of 8.8% from 2025 to 2030.
• Based on application, Oncology segment accounted for the largest market share in 2024 due to the rising global cancer burden and the growing demand for advanced diagnostic solutions.
• Based on end use, Hospitals segment held the largest market share in 2024 due to the increasing adoption of advanced imaging technologies in clinical settings.
• The diagnostic imaging centers segment is projected to be the fastest-growing segment over the forecast period, driven by the ability to offer high-quality, specialized imaging procedures with efficient turnaround times compared to larger hospitals.
• North America dominated the market with a share of 41. 4% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Molecular Imaging Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Molecular Imaging Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis

• 4.1. Modality Segment Dashboard
• 4.2. Molecular Imaging Market: Modality Movement Analysis
• 4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
• 4.4. Molecular Ultrasound Imaging
  • 4.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.5. Positron Emission Tomography (PET)
  • 4.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.6. Single Photon Emission Computed Tomography (SPECT)
  • 4.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
  • 4.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Molecular Imaging Market: Application Movement Analysis
• 5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Cardiovascular
  • 5.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 5.5. Neurology
  • 5.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 5.6. Oncology
  • 5.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 5.7. Respiratory
  • 5.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 5.8. Gastrointestinal
  • 5.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Molecular Imaging Market: End Use Movement Analysis
• 6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 6.5. Diagnostic Imaging Centers
  • 6.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 6.6. Research Institutes
  • 6.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market Share Analysis, 2024 & 2030
• 7.3. Molecular Imaging Market by Region: Key Takeaways
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key Country Dynamics
    • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.1.3. Competitive Scenario
    • 7.4.1.4. U.S. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Canada Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Mexico Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. U.K.
    • 7.5.1.1. Key Country Dynamics
    • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.1.3. Competitive Scenario
    • 7.5.1.4. U.K. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Germany Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. France Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Italy Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Spain Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.6. Denmark
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Denmark Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5.8. Norway
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.8.3. Competitive Scenario
    • 7.5.8.4. Norway Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key Country Dynamics
    • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.1.3. Competitive Scenario
    • 7.6.1.4. Japan Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. China Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. India Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Australia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Thailand Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 to 2030 (USD Million)
• 7.8. Middle East and Africa
  • 7.8.1. Middle East and Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.3.3. Competitive Scenario
    • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.4.3. Competitive Scenario
    • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.5.3. Competitive Scenario
    • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, by Key Market Participants
• 8.2. Company/ Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key Company Heat Map Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Bruker
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. GE HealthCare
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Siemens Healthineers AG
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Koninklijke Philips N.V.
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Canon Medical Systems Corporation
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Mediso Ltd.
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Cubresa Inc.
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Shimadzu Corporation
    • 8.4.8.1. Company Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. United Imaging Healthcare Co., Ltd.
    • 8.4.9.1. Company Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Positron
    • 8.4.10.1. Company Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives